Delivery Order SPE2DB22D3301-SPE2DB23FZ4WU
Award Date 9/12/23
Potential Completion Date 9/13/23
Potential Value $140K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $5,239.68 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XELJANZ XR 11 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- The Defense Logistics Agency awarded a $25,827 delivery order to Amerisourcebergen Drug Corporation for 4561401348 XELJANZ XR 11 MG tablets. The firm fixed price order is to provide 30 units of the medication and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania between July 3rd and July 5th, 2023. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen frequently supports the DLA's procurement and distribution activities for the...
- The Defense Logistics Agency awarded a $60,370.95 firm fixed price delivery order to Amerisourcebergen Drug Corporation for XELJANZ 5 MG tablets. Under this order, Amerisourcebergen will deliver 60,560 tablets to a facility in Conshohocken, Pennsylvania by July 25, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen likely supports the DLA's stockpile of prescription drugs for military treatment facilities and deploying forces under...
- The Defense Logistics Agency awarded a $3,263 delivery order to Amerisourcebergen Drug Corporation for XELJANZ 5 MG tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will provide 60 units of the specified medication to a facility located in Conshohocken, Pennsylvania by August 28, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order represents a small portion of the goods and services Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) awarded a $45,168.10 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XELJANZ XR 11 MG TABLET UU 30S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- The Defense Logistics Agency awarded a $3,198.50 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for XELJANZ XR 11 MG tablets in 30-count units. This is a firm fixed price, non-set-aside contract with performance completion scheduled for July 29, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location in the same city. The contract represents a child delivery order under...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $33,567.77 to Amerisourcebergen Drug Corporation for the supply of 4561902815 XELJANZ 5 MG tablets. Amerisourcebergen Drug Corporation will deliver 60 units of the specified medication to a facility located in Conshohocken, Pennsylvania by August 23, 2023 under the terms of the order. The prime contractor, a division of Amerisourcebergen Corporation, will fulfill the requirements on behalf of the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $1,599.24 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of XELJANZ XR 11 MG tablets in quantities of 30 units. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement....
- The Defense Logistics Agency awarded a $15,785.87 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562056178 XELJANZ XR 11 MG TABLET UU 30S. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania within a one day period of September 5-6, 2023. As a major provider of medical supplies and logistics support to the U.S. Department of Defense, this...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XELJANZ XR 11 MG tablets. The $5,121.37 order has a completion date of February 23, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. Additionally, AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...